For: | Zhao CY, Jiang LL, Li L, Deng ZJ, Liang BL, Li JM. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World J Gastroenterol 2004; 10(9): 1329-1332 [PMID: 15112352 DOI: 10.3748/wjg.v10.i9.1329] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i9/1329.htm |
Number | Citing Articles |
1 |
S. Dharancy, A. Louvet, A. Hollebecque, P. Desreumaux, P. Mathurin, L. Dubuquoy. Récepteurs nucléaires PPAR et hépatologie : implications physiopathologiques et thérapeutiques. Gastroentérologie Clinique et Biologique 2008; 32(3): 339 doi: 10.1016/j.gcb.2008.01.029
|
2 |
Araní Casillas-Ramírez, Izabel Alfany-Fernández, Marta Massip-Salcedo, M. Emília Juan, Joana M. Planas, Anna Serafín, Mercè Pallàs, Antoni Rimola, Juan Rodés, Carmen Peralta. Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver Transplantation. Journal of Pharmacology and Experimental Therapeutics 2011; 338(1): 143 doi: 10.1124/jpet.110.177691
|
3 |
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study. Cancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
|
4 |
Jhao-Ru Lai, Ya-Wen Hsu, Tzu-Ming Pan, Chun-Lin Lee. Monascin and Ankaflavin of Monascus purpureus Prevent Alcoholic Liver Disease through Regulating AMPK-Mediated Lipid Metabolism and Enhancing Both Anti-Inflammatory and Anti-Oxidative Systems. Molecules 2021; 26(20): 6301 doi: 10.3390/molecules26206301
|
5 |
Nora A. Ashry, Rania R. Abdelaziz, Ghada M. Suddek. The potential effect of imatinib against hypercholesterolemia induced atherosclerosis, endothelial dysfunction and hepatic injury in rabbits. Life Sciences 2020; 243: 117275 doi: 10.1016/j.lfs.2020.117275
|
6 |
Kenichi Harada, Kumiko Isse, Takashi Kamihira, Shinji Shimoda, Yasuni Nakanuma. Th1 cytokine–induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis†. Hepatology 2005; 41(6): 1329 doi: 10.1002/hep.20705
|
7 |
Bessem Mornagui, Raja Rezg, Fadoua Neffati, Mohamed Fadhel Najjar, Ahmed Rejeb. Postnatal exposure to Bisphenol S induces liver injury in mice: Possible implication of PPARγ receptor. Toxicology and Industrial Health 2023; 39(5): 237 doi: 10.1177/07482337231166490
|
8 |
Jhao-Ru Lai, Bo-Jun Ke, Ya-Wen Hsu, Chun-Lin Lee. Dimerumic acid and deferricoprogen produced by Monascus purpureus attenuate liquid ethanol diet-induced alcoholic hepatitis via suppressing NF-κB inflammation signalling pathways and stimulation of AMPK-mediated lipid metabolism. Journal of Functional Foods 2019; 60: 103393 doi: 10.1016/j.jff.2019.05.049
|
9 |
Sapana Bansod, Mohd Aslam Saifi, Chandraiah Godugu. Molecular updates on berberine in liver diseases: Bench to bedside. Phytotherapy Research 2021; 35(10): 5459 doi: 10.1002/ptr.7181
|
10 |
Elena Grasselli, Adriana Voci, Ilaria Demori, Rita De Matteis, Andrea D. Compalati, Gabriella Gallo, Laura Vergani. Effects of binge ethanol on lipid homeostasis and oxidative stress in a rat model of nonalcoholic fatty liver disease. Journal of Physiology and Biochemistry 2014; doi: 10.1007/s13105-013-0308-x
|
11 |
Warinda Susutlertpanya, Duangporn Werawatganon, Prasong Siriviriyakul, Naruemon Klaikeaw. Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγin a Rat Model. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/509057
|
12 |
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World Journal of Hepatology 2020; 12(7): 364 doi: 10.4254/wjh.v12.i7.364
|
13 |
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World Journal of Hepatology 2020; 12(7): 363-377 doi: 10.4254/wjh.v12.i7.363
|
14 |
Xin Xin, Cheng Chen, Yi-Yang Hu, Qin Feng. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomedicine & Pharmacotherapy 2019; 117: 109047 doi: 10.1016/j.biopha.2019.109047
|
15 |
Suchittra Samuhasaneeto, Duangporn Thong-Ngam, Onanong Kulaputana, Doungsamon Suyasunanont, Naruemon Klaikeaw, Stelvio M. Bandiera. Curcumin Decreased Oxidative Stress, Inhibited NF‐κB Activation, and Improved Liver Pathology in Ethanol‐Induced Liver Injury in Rats. BioMed Research International 2009; 2009(1) doi: 10.1155/2009/981963
|
16 |
Chuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li, Jian Gao. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-39
|
17 |
WEIHAN ZHAO, LIJUAN LIU, YUNLIANG WANG, TANGYOU MAO, JUNXIANG LI. Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease. Experimental and Therapeutic Medicine 2016; 11(1): 183 doi: 10.3892/etm.2015.2846
|
18 |
Nora A. Ashry, Rania R. Abdеlaziz, Ghada M. Suddek, Mohamed A. Saleh. Canagliflozin ameliorates aortic and hepatic dysfunction in dietary-induced hypercholesterolemia in the rabbit. Life Sciences 2021; 280: 119731 doi: 10.1016/j.lfs.2021.119731
|
19 |
H ELKATTAWY, D MAHMOUD ABDELMONEM ELSHERBINI, H ALI EBRAHIM, D ABDULLAH, S AL-ZAHABY, Y NOSERY, A EL-SAYED HASSAN. Rho-Kinase Inhibition Ameliorates Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Rats. Physiological Research 2022; : 615 doi: 10.33549/physiolres.934869
|
20 |
M. Elias-Miró, M. B. Jiménez-Castro, M. Mendes-Braz, A. Casillas-Ramírez, C. Peralta. The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/802384
|